S-1226
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for S-1226, covering 2021-06-16 to 2021-08-23. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms. [Phase 2]